Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-500,000
Closed -$1.96M 7627
2018
Q4
$1.96M Buy
+500,000
New +$2.13M ﹤0.01% 2685
2016
Q4
Sell
-2,000
Closed -$12K 7166
2016
Q3
$12K Buy
+2,000
New +$12K ﹤0.01% 6440

Other funds holding ABEV

Citigroup's ABEV Position: Q2 2026 in Review

Citigroup increased its Ambev (ABEV) stake by 0.7% in Q2 2026, buying an estimated $16.4K and bringing the position to 752,146 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

Citigroup first reported a position in ABEV in Q4 2013 and has held it in 51 quarters since. The position peaked at $105M in Q3 2017. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Citigroup held 752,146 shares of Ambev worth $2.36M as of Q2 2026.
  • Citigroup bought 5,242 Ambev shares in Q2 2026, an estimated $16.4K.
  • Ambev made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2805 holding.
  • Citigroup first reported a position in Ambev in Q4 2013 and has held it in 51 quarters since.
  • Citigroup's Ambev position peaked at $105M in Q3 2017.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.